Pneumococcal aortitis in the antibiotic era

J P Ioannidis1, F Merino, M S Drapkin

  • 1Division of Geographic Medicine and Infectious Diseases, New England Medical Center Hospitals, Boston, Mass, USA.

Insights

Streptococcus pneumoniae can cause fatal thoracic aortitis, even with antibiotic treatment. This rare complication affects both native and grafted aortas, often presenting subtly.

Area of Science:

  • Infectious Diseases
  • Cardiovascular Medicine
  • Pathogen Research

Background:

  • Streptococcus pneumoniae is a significant pathogen during the antibiotic era.
  • Atypical and lethal presentations of pneumococcal infections are well-documented.
  • Thoracic aortitis is a rare but severe vascular complication.

Observation:

  • Two fatal cases of thoracic aortitis caused by Streptococcus pneumoniae bacteremia are presented.
  • One case involved an aortic graft, while the other affected a native aorta.
  • The clinical presentation was indolent, with diagnostic challenges.

Findings:

  • Transesophageal echocardiography and leukocyte scintigraphy failed to diagnose the aortitis in both cases.
  • The pathogen identified was Streptococcus pneumoniae, leading to fatal thoracic aortitis.
  • The complication occurred in both prosthetic and native aortic tissues.

Implications:

  • Clinicians should consider thoracic aortitis as a rare complication of pneumococcal disease.
  • Persistent fever, atypical chest pain, and unexplained bleeding warrant investigation for this condition.
  • Early recognition and diagnosis are crucial for managing this lethal complication of pneumococcal infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...